← All stocks

BIOCRYST PHARMACEUTICALS INC

BCRX Mostly scheduled

CIK 0000882796 #1887 in the set updated 19 Sep 2026

Bought (12 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$4.14M

$915.82K on a plan · $3.12M straight out of an exercise

Sold at will

$100.28K

1 of 10 sales

Net

−$4.14M

−$100.28K against sales at will

By person

16 insiders · 14 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Barnes Alane P

Chief Legal Officer

—

$3.46M (7) scheduled

−$3.46M

400,703

0.1568%

$3.59M

+29.9%

HEGGIE THERESA

Director

—

$504.82K (1) scheduled

−$504.82K

80,646

0.0316%

$723.39K

+52.6%

McKee Amy E

Director

—

$100.28K (1)

−$100.28K

47,821

0.0187%

$428.95K

+71.8%

SANDERS MACHELLE

Director

—

$68.54K (1) scheduled

−$68.54K

45,936

0.0180%

$412.05K

+65.6%

Stonehouse Jon P

Director

—

1,460,419

0.5715%

$13.10M

+20.5%

Gayer Charles K

President and CCO

—

952,583

0.3728%

$8.54M

+205.5%

Doyle Anthony

Chief Financial Officer

—

377,867

0.1479%

$3.39M

+41.2%

Thackray Helen M.

Chief R&D Officer

—

377,318

0.1477%

$3.38M

+38.6%

Ghias Babar

Chief Financial Officer

—

268,700

0.1052%

$2.41M

—

Menon Sandeep

Chief R&D Officer

—

205,150

0.0803%

$1.84M

—

MILANO VINCENT

Director

—

109,642

0.0429%

$983.49K

+45.5%

Hutson Nancy J

Director

—

99,138

0.0388%

$889.27K

+5.9%

LEVIN ALAN G

Director

—

79,565

0.0311%

$713.70K

+53.7%

Frank Steven

Director

—

36,747

0.0144%

$329.62K

—

Milne Jill C.

Director

—

33,226

0.0130%

$298.04K

—

Galson Steven K

Director

—

27,794

0.0109%

$249.31K

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

Stonehouse Jon P

2 Mar 2026

Director

Exercised, kept

305,995

$3.22

$985.30K

Gayer Charles K

22 Dec 2025

President and CCO

Exercised, kept

50,000

$5.51

$275.50K

Gayer Charles K

22 Dec 2025

President and CCO

Exercised, kept

10,091

$5.04

$50.86K

Gayer Charles K

22 Dec 2025

President and CCO

Exercised, kept

14,142

$3.22

$45.54K

Show all 14 transactions →

What was left out

Form 4 filings counted 45

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 5

Sales straight out of an exercise 4

Sales at will 1

Transactions with no price 0

Shares from compensation/vesting 2,302,758

History held since 6 Sep 2016